XWELL Crecimiento futuro

Future controles de criterios 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for XWELL.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Consumer Services	26.0%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Slammed 27% XWELL, Inc. (NASDAQ:XWEL) Screens Well Here But There Might Be A Catch

Sep 06

XWELL, Inc. (NASDAQ:XWEL) Might Not Be As Mispriced As It Looks After Plunging 29%

Jul 14

It's Down 27% But XWELL, Inc. (NASDAQ:XWEL) Could Be Riskier Than It Looks

Apr 03

Further Upside For XWELL, Inc. (NASDAQ:XWEL) Shares Could Introduce Price Risks After 33% Bounce

Feb 15

These 4 Measures Indicate That XpresSpa Group (NASDAQ:XSPA) Is Using Debt Safely

May 10

Rock star Growth Puts XpresSpa Group (NASDAQ:XSPA) In A Position To Use Debt

Jan 11

XpresSpa Is A Strong Buy With Covid Testing Earnings Power

Dec 13

We Think The Compensation For XpresSpa Group, Inc.'s (NASDAQ:XSPA) CEO Looks About Right

Sep 24

Analysts Have Been Trimming Their XpresSpa Group, Inc. (NASDAQ:XSPA) Price Target After Its Latest Report

Aug 19

Is XpresSpa Group (NASDAQ:XSPA) Weighed On By Its Debt Load?

Jun 22

XpresSpa Group to be a part of Russell Microcap Index

Jun 09

XpresSpa launches a new travel brand 'Treat'

Jun 01

XpresSpa Group Stock Forecast: What To Think About After 2020 Q4 Earnings

May 04

XpresSpa Uniquely Positioned To Benefit As Airport COVID-19 Testing Gains Momentum

Feb 04

XpresSpa hits session highs as CEO set to appear on Fox Business

Jan 05

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como XWELL no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

NasdaqCM:XWEL - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
6/30/2024	33	-21	-13	-12	N/A
3/31/2024	32	-25	-15	-14	N/A
12/31/2023	30	-28	-18	-16	N/A
9/30/2023	30	-35	-23	-20	N/A
6/30/2023	34	-32	-28	-24	N/A
3/31/2023	39	-34	-35	-28	N/A
12/31/2022	56	-33	-31	-24	N/A
9/30/2022	78	-16	-18	-9	N/A
6/30/2022	94	-3	-2	8	N/A
3/31/2022	89	0	8	16	N/A
12/31/2021	74	3	7	15	N/A
9/30/2021	45	-16	-8	-2	N/A
6/30/2021	18	-27	-21	-15	N/A
3/31/2021	9	-82	-30	-25	N/A
12/31/2020	8	-91	-29	-25	N/A
9/30/2020	18	-83	-20	-16	N/A
6/30/2020	30	-82	-15	-12	N/A
3/31/2020	43	-29	-6	-4	N/A
12/31/2019	47	-21	-2	0	N/A
9/30/2019	50	-21	-5	-3	N/A
6/30/2019	50	-19	-5	-3	N/A
3/31/2019	50	-16	-6	-4	N/A
12/31/2018	50	-36	-9	-7	N/A
9/30/2018	50	-32	-11	-6	N/A
6/30/2018	50	-33	-13	-8	N/A
3/31/2018	50	-35	N/A	-10	N/A
12/31/2017	49	-17	N/A	-12	N/A
9/30/2017	32	-15	N/A	-16	N/A
6/30/2017	23	-16	N/A	-17	N/A
3/31/2017	21	-20	N/A	-8	N/A
12/31/2016	12	-19	N/A	-8	N/A
9/30/2016	39	-2	N/A	8	N/A
6/30/2016	36	-9	N/A	6	N/A
3/31/2016	25	-8	N/A	-4	N/A
12/31/2015	23	-11	N/A	-3	N/A
9/30/2015	0	-103	N/A	-22	N/A
6/30/2015	1	-104	N/A	-23	N/A
3/31/2015	1	-105	N/A	-23	N/A
12/31/2014	1	-109	N/A	-28	N/A
9/30/2014	1	-44	N/A	-26	N/A
6/30/2014	1	-42	N/A	-25	N/A
3/31/2014	1	-42	N/A	-27	N/A
12/31/2013	1	-42	N/A	-23	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Insufficient data to determine if XWEL's forecast earnings growth is above the savings rate (2.5%).

Beneficios vs. Mercado: Insufficient data to determine if XWEL's earnings are forecast to grow faster than the US market

Beneficios de alto crecimiento: Insufficient data to determine if XWEL's earnings are expected to grow significantly over the next 3 years.

Ingresos vs. Mercado: Insufficient data to determine if XWEL's revenue is forecast to grow faster than the US market.

Ingresos de alto crecimiento: Insufficient data to determine if XWEL's revenue is forecast to grow faster than 20% per year.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Insufficient data to determine if XWEL's Return on Equity is forecast to be high in 3 years time

XWELL Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Consensus revenue estimates fall by 33%

Consensus EPS estimates fall by 12%

Consensus revenue estimates fall by 14%

Price target decreased to US$2.00

Price target decreased to US$2.00

XpresSpa Group Announces the Re-Opening of XpresSpa™ Location At John F. Kennedy International Airport’s Terminal 4

Recent updates

Slammed 27% XWELL, Inc. (NASDAQ:XWEL) Screens Well Here But There Might Be A Catch

XWELL, Inc. Announces Executive Changes

XWELL, Inc., Annual General Meeting, Sep 20, 2024

Second quarter 2024 earnings released: US$0.48 loss per share (vs US$1.37 loss in 2Q 2023)

CPC Decides to Withdraw Lawsuit Against XWELL

New minor risk - Shareholder dilution

XWELL, Inc. has completed a Follow-on Equity Offering in the amount of $1.422897 million.

New major risk - Share price stability

XWELL, Inc. has filed a Follow-on Equity Offering in the amount of $1.422897 million.

CPC Pain & Wellness SPV Files Complaint in the Delaware Court of Chancery Against XWELL

XWELL, Inc. (NASDAQ:XWEL) Might Not Be As Mispriced As It Looks After Plunging 29%

CPC Pain & Wellness SPV Engages in Discussions with XWELL

XWELL, Inc. Introduces New Esthetic Facial Services to Naples Wax Center Locations

XWELL, Inc. Plans to Introduce the Ceragem V6 Therapeutic Thermal Massager in Select Xpresspa Locations

XWELL, Inc. Introduces IV Hydration Drip Therapy at Miami International Airport

XWELL, Inc. to Report Fiscal Year 2023 Results on Apr 16, 2024

XWELL, Inc. announced delayed amended 10-K filing

XWELL, Inc. announced delayed annual 10-K filing

It's Down 27% But XWELL, Inc. (NASDAQ:XWEL) Could Be Riskier Than It Looks

Further Upside For XWELL, Inc. (NASDAQ:XWEL) Shares Could Introduce Price Risks After 33% Bounce

XWELL, Inc. Elects Gaëlle S. Wizenberg as Member of the Audit Committee and the Compensation Committee

Not Many Are Piling Into XWELL, Inc. (NASDAQ:XWEL) Stock Yet As It Plummets 29%

XWELL, Inc. Announces Board Changes, Effective January 1, 2024

XWELL, Inc. Introduces Clockwork Robotic Manicures At Harry Reid International Airport in Las Vegas

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

XWELL, Inc. Reports Impairment Charges for the Third Quarter Ended September 30, 2023

XWELL, Inc. Announces 1-for-20 Reverse Stock Split to Regain Compliance with Minimum Bid Price Requirement for Continued Listing on The Nasdaq Capital Market

XWELL, Inc. (NasdaqCM:XWEL) acquired Naples Wax Center, Inc.

Second quarter 2023 earnings: Revenues and EPS in line with analyst expectations

XWELL, Inc. to Report Q2, 2023 Results on Aug 14, 2023

XWELL, Inc., Annual General Meeting, Aug 22, 2023

Xpresspa Debuts Clockwork Robotic Manicures At Miami International Airport

New minor risk - Share price stability

XWELL (NASDAQ:XWEL) Will Have To Spend Its Cash Wisely

XWELL, Inc. Announces Executive Changes, Effective July 10, 2023

XWELL, Inc. to Report Q1, 2023 Results on May 15, 2023

XWELL, Inc. Names Valerie Lightfoot Chief Financial Officer

Consensus revenue estimates fall by 33%

Full year 2022 earnings: EPS misses analyst expectations

There's No Escaping XWELL, Inc.'s (NASDAQ:XWEL) Muted Revenues

Consensus EPS estimates fall by 12%

Consensus revenue estimates fall by 14%

Price target decreased to US$2.00

Third quarter 2022 earnings released: US$0.076 loss per share (vs US$0.053 profit in 3Q 2021)

Price target decreased to US$2.00

XWELL, Inc. Announces Impairment Charges for the Three Months Ended September 30, 2022

XWELL, Inc. to Report Q3, 2022 Results on Nov 10, 2022

XWELL, Inc. Receives Non-Compliance Letter from the Nasdaq

XpresSpa Group, Inc. Regains Compliance with Nasdaq Listing Rule 5550(a)(2)

XpresSpa Group, Inc., Annual General Meeting, Oct 04, 2022

XpresSpa Group Announces the Re-Opening of XpresSpa™ Location At John F. Kennedy International Airport’s Terminal 4

XpresSpa Q2 2022 Earnings Preview

XpresSpa Group, Inc. to Report Q2, 2022 Results on Aug 15, 2022

XpresSpa Group Announces the Separation of Service of Chief Financial Officer James Berry

Consensus revenue estimates fall by 36%

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

XpresSpa Group, Inc. Revises Revenue Guidance for the Year 2022

XpresSpa Group, Inc. to Report Q1, 2022 Results on May 16, 2022

These 4 Measures Indicate That XpresSpa Group (NASDAQ:XSPA) Is Using Debt Safely

Price target increased to US$4.00

Xpresspa Group, Inc. Announces Travel Health and Wellness Brand Treat™ Launches At Phoenix Sky Harbor International Airport

XpresSpa Group, Inc. Announces the Addition of Five New Xpresspa Locations in Istanbul

Investor sentiment improved over the past week

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

XpresSpa Group, Inc. Announces Resignation of Douglas Satzman as President

XpresSpa Group, Inc. (NasdaqCM:XSPA) entered into an acquisition agreement to acquire Gcg Connect Llc.

Rock star Growth Puts XpresSpa Group (NASDAQ:XSPA) In A Position To Use Debt

Independent Chairman of the Board recently bought US$64k worth of stock

XpresSpa Is A Strong Buy With Covid Testing Earnings Power